The FDA has approved popular antiobesity drug Ozempic to help protect patients with type 2 diabetes from kidney disease.

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Results from a case series identified a potential association between ophthalmic complications and the rapid correction of hyperglycemia, brought on by patients using either semaglutide or tirzepatide ...

Sociodemographic, health care, and clinical factors are associated with receipt of semaglutide in those with obesity but without diabetes.

The Food and Drug Administration approved Novo Nordisk’s Ozempic as the first GLP-1 treatment option for people with type 2 ...

The US Food and Drug Administration (FDA) has approved Novo Nordisk’s Ozempic (semaglutide) to reduce certain risks ...

Alexandra Sowa's new book The Ozempic Revolution is intended to be the "first comprehensive user guide" to GLP-1 drugs like ...

Semaglutide, the popular drug sold by Novo ... allowing for more meetings with drugmakers and greater input from patients and physicians. The pharma industry has lambasted the process as ...

The European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) has started a review of medicines containing semaglutide following concerns regarding an increased risk of ...

Semaglutide, the popular drug sold by Novo Nordisk as Ozempic ... allowing for more meetings with drugmakers and greater input from patients and physicians. The pharma industry has lambasted the ...

GB News spoke to patients at Goole District Hospital, where this week hundreds of people gathered amid speculation about the future of the town's hospital. It came as concerns were raised last month ...

GetSimpli Oral Semaglutide offers a promising solution for those looking to enhance their overall well-being, manage their weight, and improve metabolic health. As an innovative sublingual tablet ...